Baiama 40 mg/ml
Baiama 40 mg/ml is a medicine authorised by Swissmedic under authorisation number 70292. The authorisation holder is Horus Pharma Suisse SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 November 2025 and the authorisation is limited until 09 November 2030. ATC code S01LA05 places the medicine in the group Ophthalmologicals.
| Authorisation number | 70292 |
|---|---|
| Name | Baiama 40 mg/ml |
| Full name | Baiama 40 mg/ml, solution injectable |
| Authorisation holder | Horus Pharma Suisse SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | S01LA05 |
| First authorisation | 10 November 2025 |
| Authorisation validity | 09 November 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Baiama 40 mg/ml, solution injectable | B | 10 November 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | S01LA05 | 11.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Baiama 40 mg/ml authorised in Switzerland?
Yes. Baiama 40 mg/ml is authorised by Swissmedic under authorisation number 70292, data as of 01 September 2026. The authorisation is limited until 09 November 2030.
Which dispensing category does Baiama 40 mg/ml have?
Baiama 40 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Baiama 40 mg/ml?
The authorisation holder is Horus Pharma Suisse SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.